In Vivo Expression Pattern of MICA and MICB and Its Relevance to Auto-Immunity and Cancer

PLoS ONE

Volumn 2, Issue 6, 2007, Pages

  Schrambach, Stéphanie ^a,b   Ardizzone, Marc ^a,b   Leymarie, Vincent ^a   Sibilia, Jean ^a   Bahram, Seiamak ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, HUMAN; MESSENGER RNA; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; NORTHERN BLOTTING; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SALIVARY GLAND; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BLOTTING, NORTHERN; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOENZYME TECHNIQUES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 36249023845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000518     Document Type: Article

References (50)

1. Rudolph MG, Stanfield RL, Wilson IA, (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419-466.
2. Romero P, Cerottini JC, Speiser DE, (2006) The human T cell response to melanoma antigens. Adv Immunol 92: 187-224.
3. Castellino F, Germain RN, (2006) Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 24: 519-540.
4. Benoist C, Mathis D, (2000) A revival of the B cell paradigm for rheumatoid arthritis pathogenesis? Arthritis Res 2: 90-94.
5. Mathis D, Benoist C, (2004) Back to central tolerance. Immunity 20: 509-516.
6. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, et al.(2002) Arthritis critically dependent on innate immune system players. Immunity 16: 157-168.
7. Bahram S, Bresnahan M, Geraghty DE, Spies T, (1994) A second lineage of mammalian major histocompatibility complex class I genes [see comments]. Proc Natl Acad Sci U S A 91: 6259-6263.
8. Bahram S, (2000) MIC genes: from genetics to biology. Adv Immunol 76: 1-60.
9. Bahram S, Inoko H, Shiina T, Radosavljevic M, (2005) MIC and other NKG2D ligands: from none to too many. Curr Opin Immunol 17: 505-509.
10. Lanier LL, (2005) NK cell recognition. Annu Rev Immunol 23: 225-274.
11. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, et al.(2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2: 255-260.
12. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, et al.(2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366.
13. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, et al.(1999) Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 96: 6879-6884.
14. Das H, Groh V, Kuijl C, Sugita M, Morita CT, et al.(2001) Mica engagement by human vgamma2vdelta2 t cells enhances their antigen- dependent effector function. Immunity 15: 83-93.
15. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T, (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 100: 9452-9457.
16. Klareskog L, Padyukov L, Ronnelid J, Alfredsson L, (2006) Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 18: 650-655.
17. Monach PA, Benoist C, Mathis D, (2004) The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv Immunol 82: 217-248.
18. Schmidt D, Goronzy JJ, Weyand CM, (1996) CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97: 2027-2037.
19. Goronzy JJ, Weyand CM, (2005) Rheumatoid arthritis. Immunol Rev 204: 55-73.
20. Janeway C, Travers P, Walport M, Shlomchik M, (2004) Immunobiology: The Immune System in Health and Disease London Garland Science pp. 800.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al.(1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
22. Hochberg MC, (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
23. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, et al.(2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
24. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, et al.(1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 93: 12445-12450.
25. Firestein GS, (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
26. Lohr J, Knoechel B, Nagabhushanam V, Abbas AK, (2005) T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol Rev 204: 116-127.
27. Rioux JD, Abbas AK, (2005) Paths to understanding the genetic basis of autoimmune disease. Nature 435: 584-589.
28. Walker LS, Abbas AK, (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2: 11-19.
29. Ogasawara K, Lanier LL, (2005) NKG2D in NK and T cell-mediated immunity. J Clin Immunol 25: 534-540.
30. Radosavljevic M, Cuillerier B, Wilson MJ, Clement O, Wicker S, et al.(2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 79: 114-123.
31. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, et al.(2001) ULBPs, Novel MHC Class I-Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor. Immunity 14: 123-133.
32. Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, et al.(2005) HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 105: 251-258.
33. Girlanda S, Fortis C, Belloni D, Ferrero E, Ticozzi P, et al.(2005) MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes. Cancer Res 65: 7502-7508.
34. Amezaga N, Crespo M, Lopez-Cobos M, Millan MA, Vinas O, et al.(2006) Relevance of MICA antibodies in acute humoral rejection in renal transplant patients. Transpl Immunol 17: 39-42.
35. Busche A, Goldmann T, Naumann U, Steinle A, Brandau S, (2006) Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A. Hum Gene Ther 17: 135-146.
36. Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, et al.(2003) MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Res 63: 8996-9006.
37. McCann FE, Eissmann P, Onfelt B, Leung R, Davis DM, (2007) The Activating NKG2D Ligand MHC Class I-Related Chain A Transfers from Target Cells to NK Cells in a Manner That Allows Functional Consequences. J Immunol 178: 3418-3426.
38. Shawar SM, Vyas JM, Rodgers JR, Rich RR, (1994) Antigen presentation by major histocompatibility complex class I-B molecules. Annu Rev Immunol 12: 839-880.
39. Lindahl KF, Byers DE, Dabhi VM, Hovik R, Jones EP, et al.(1997) H2-M3, a full-service class Ib histocompatibility antigen. Annu Rev Immunol 15: 851-879.
40. Fodil N, Pellet P, Laloux L, Hauptmann G, Theodorou I, et al.(1999) MICA haplotypic diversity. Immunogenetics 49: 557-560.
41. Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, et al.(2006) Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev 5: 180-186.
42. Hansen A, Lipsky PE, Dorner T, (2003) New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr Opin Rheumatol 15: 563-570.
43. Wagner U, Pierer M, Kaltenhauser S, Wilke B, Seidel W, et al.(2003) Clonally expanded CD4+CD28null T cells in rheumatoid arthritis use distinct combinations of T cell receptor BV and BJ elements. Eur J Immunol 33: 79-84.
44. Saez-Borderias A, Guma M, Angulo A, Bellosillo B, Pende D, et al.(2006) Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 36: 3198-3206.
45. James JA, Harley JB, Scofield RH, (2001) Role of viruses in systemic lupus erythematosus and Sjogren syndrome. Curr Opin Rheumatol 13: 370-376.
46. Perera L, Shao L, Patel A, Evans K, Meresse B, et al.(2007) Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis 13: 298-307.
47. Orchard TR, Dhar A, Simmons JD, Vaughan R, Welsh KI, et al.(2001) MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy. Clin Exp Immunol 126: 437-440.
48. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH, (2002) Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20: 853-885.
49. Strong RK, (2002) Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer. Mol Immunol 38: 1029-1037.
50. Bahram S, Spies T, (1996) Nucleotide sequence of a human MHC class I MICB cDNA. Immunogenetics 43: 230-233.